Explore Prof. Wong's insights on MASLD treatment advancements from AASLD, featuring key drugs like Resmetirom, Lanifibranor, and Semaglutide with a focus on Lanifibranor
The multinational liver societies introduce a non-stigmatizing and affirming nomenclature for "Fatty" liver diseases, striving for a global consensus to advance research, funding, and patient care.
Engage in an immersive experience of cross-disciplinary knowledge exchange at the upcoming MOSAIC - Global NASH Trialist Forum 2023, an essential gathering committed to addressing Non-alcoholic Steatohepatitis (NASH) through multi-specialty clinical trials
Liver health professionals from around the world are set to meet in Boston for The Liver Meeting 2023 (TLM23). This premiere conference on liver diseases takes place at the Hynes Convention Center, from November 10-14, 2023.
On International NASH Day 2023, PanNASH amplifies the importance of NASH awareness, education, and action. Learn about the complex multisystem nature of NASH, the potential of PPAR agonists in NASH management, and the role of healthcare professionals in delivering effective, patient-centered care. Discover how PanNASH resources are empowering the medical community and join us in taking action against NASH.
The 9th edition of the Paris NASH meeting will be held this year where key opinion leaders of the industry will discuss the latest on NASH clinical trials, management and diagnosis of non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Immerse yourself in an interactive experience of scientific exchange and multidisciplinary collaboration at the EASL NAFLD Summit 2023 in Prague, the premier gathering for healthcare professionals committed to tackling Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
EASL, the European Association for the Study of the Liver, founded in 1966, is a medical association dedicated to pursuing excellence in liver research, to the clinical practice of liver disorders, and to providing education to all those interested in hepatology. As of 2022, EASL serves 4,900 members from 112 countries.
The AASLD is a leading organization dedicated to the prevention and cure of liver disease. It promotes research that leads to better treatment options for liver disease patients. The organization also advances the field of hepatology through education, training, professional publications, and partnerships.